{
  "id": "35de3b8956217e72",
  "title": "Outlook Therapeutics , tonfo nel pre - market su mancata approvazione della FDA",
  "description": "20260102T143000Z",
  "content": "",
  "source": "finanza.lastampa.it",
  "source_url": "https://finanza.lastampa.it/News/2026/01/02/outlook-therapeutics-tonfo-nel-pre-market-su-mancata-approvazione-della-fda/MTA1XzIwMjYtMDEtMDJfVExC",
  "published_at": "20260102T143000Z",
  "fetched_at": "2026-01-03T00:22:18.884957+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Italy",
  "raw_data": {
    "url": "https://finanza.lastampa.it/News/2026/01/02/outlook-therapeutics-tonfo-nel-pre-market-su-mancata-approvazione-della-fda/MTA1XzIwMjYtMDEtMDJfVExC",
    "url_mobile": "",
    "title": "Outlook Therapeutics , tonfo nel pre - market su mancata approvazione della FDA",
    "seendate": "20260102T143000Z",
    "socialimage": "https://images.teleborsa.it/t/stabile/116775.t.W600.H340.M4.jpg",
    "domain": "finanza.lastampa.it",
    "language": "Italian",
    "sourcecountry": "Italy"
  }
}